Home
Mustang Bio

Mustang Bio Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainmustangbio.com

Year Founded2015

Employees51 - 200

Annual Revenue$25M - $50M

Mustang Bio

Mustang Bio (including company regionals)

mustangbio.com

See more website traffic and engagement information

Mustang Bio Revenue up to June 2026 is 25M - 50M

revenue generated by Mustang Bio top domains

Mustang Bio top domains revenue over 3 years

Revenue for Mustang Bio top domains

mustangbio.com25M - 50M

See more with Sales Intelligence

Total visits to Mustang Bio's top domains

Understand Mustang Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

mustangbio.com3.5K

See more with Sales Intelligence

Avg. visit duration in Mustang Bio's top domains

Analyze Mustang Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

mustangbio.com00:00:30

See more with Sales Intelligence

Avg. pageviews on Mustang Bio's top domains

See how Mustang Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

mustangbio.com1.69

See more with Sales Intelligence

Mustang Bio top competitors by domain

Top similar sites in June 2026, ranked by their affinity

tgtherapeutics.comCompany NameTG TherapeuticsEmployees201 - 500HQUnited States, New York, New York CityAnnual revenue$500M - $1BTotal visits66.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Mustang Bio

These are the website technologies, by industry, used by Mustang Bio top domains

Widget (5)

Twemoji

Advertising (4)

Google Adsense

Audio Video Media (2)

YouTube

Content Management System (2)

WordPress

More Technologies

6

See all

News & Signals from Mustang Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMustang Bio, Inc. expands facilities to Worcester, Massachusetts, United States, Northern America, Americas.Meanwhile, in an attached exhibit (Exhibit 99.1) to its filing, Mustang Bio, Inc. (Nasdaq: MBIO) announced the divestiture of fixed assets and the exit from the lease for its manufacturing facility in Worcester, Massachusetts.

NewsMustang Bio, Inc. sold assets to AbbVie in the amount of $2M on Feb 27th '25.Meanwhile, Mustang Bio (NASDAQ:MBIO) has sold certain assets to AbbVie and terminated its lease agreement early, resulting in anticipated savings of approximately $2 million in lease-related expenses.